ASCO in the 21st century: challenges and opportunities--ASCO presidential address 2005.
Johnson
David H
DH
Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
D000970:Antineoplastic Agents / Q000009:adverse effects; D016265:Conflict of Interest; D004992:Ethics, Medical; D006801:Humans; D008495:Medical Oncology; D011785:Quality Assurance, Health Care; D012106:Research; D012449:Safety; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents